NRX Pharmaceuticals Warrant
NRXPW
NRXPW was delisted on the 22nd of May, 2026.
5 hedge funds and large institutions have $10.2K invested in NRX Pharmaceuticals Warrant in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 3 closing their positions.
71% more capital invested
Capital invested by funds: $5.93K → $10.2K (+$4.22K)
0.48% less ownership
Funds ownership: 1.13% → 0.65% (-0.48%)
38% less funds holding
Funds holding: 8 → 5 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$783 |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$704 |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$634 |
| 4 |
VF
Virtu Financial
New York
|
-$570 |
| 5 |
JFGIW
Johnson Financial Group Inc (Wisconsin)
Racine,
Wisconsin
|
-$15 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Truist Financial
Charlotte,
North Carolina
| $4.99K | – | – | – |
|
|
VF
2
Virtu Financial
New York
| $4K | -$570 | -9,172 | -26% |
|
|
WAM
3
Wolverine Asset Management
Chicago,
Illinois
| $664 | -$634 | -10,202 | -66% |
|
|
4
UBS Group
Zurich,
Switzerland
| $501 | -$704 | -11,340 | -74% |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $2 | – | – | – |
|
|
TSS
6
Two Sigma Securities
New York
| – | -$783 | -17,400 | Closed |
|
|
JFGIW
7
Johnson Financial Group Inc (Wisconsin)
Racine,
Wisconsin
| – | -$15 | -315 | Closed |
|
8
Bank of America
Charlotte,
North Carolina
| – | -$4 | -95 | Closed |
|
NRXPW Hedge Fund Activity: Q4 2024 in Review
5 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in NRX Pharmaceuticals Warrant (NRXPW) for Q4 2024, worth a combined $10.2K — up 71% from $5.93K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of NRXPW and 0 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 0 added.
The largest seller was Two Sigma Securities, exiting entirely with an estimated $783 sold.
- 5 institutional investors held NRX Pharmaceuticals Warrant (NRXPW) as of Q4 2024, down from 8 in Q3 2024.
- Funds reported $10.2K of NRX Pharmaceuticals Warrant stock for Q4 2024, up 71% quarter-over-quarter.
- 0 funds opened new NRX Pharmaceuticals Warrant positions in Q4 2024 and 3 closed out, a net change of -3 holders.
- The largest NRX Pharmaceuticals Warrant seller in Q4 2024 was Two Sigma Securities, an estimated $783 sold.
Based on aggregated 13F filings for Q4 2024.